Literature DB >> 15471885

Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis.

Thelma Thompson1, Christian Tovar, Hong Yang, Daisy Carvajal, Binh T Vu, Qunli Xu, Geoffrey M Wahl, David C Heimbrook, Lyubomir T Vassilev.   

Abstract

The p53 tumor suppressor is a key mediator of the cellular response to stress. Phosphorylation induced by multiple stress-activated kinases has been proposed to be essential for p53 stabilization, interaction with transcriptional co-activators, and activation of p53 target genes. However, genetic studies suggest that stress-activated phosphorylation may not be essential for p53 activation. We therefore investigated the role of p53 phosphorylation on six key serine residues (Ser(6), Ser(15), Ser(20), Ser(37), Ser(46), and Ser(392)) for p53 activation using nutlin-3, a recently developed small molecule MDM2 antagonist. We show here that nutlin does not induce the phosphorylation of p53. Comparison of the activity of unphosphorylated and phosphorylated p53 induced by the genotoxic drugs doxorubicin and etoposide in HCT116 and RKO cells revealed no difference in their sequence-specific DNA binding and ability to transactivate p53 target genes and to induce p53-dependent apoptosis. We conclude that p53 phosphorylation on six major serine sites is not required for activation of p53 target genes or biological responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471885     DOI: 10.1074/jbc.M410233200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

2.  Stimulus-specific transcriptional regulation within the p53 network.

Authors:  Aaron Joseph Donner; Jennifer Michelle Hoover; Stephanie Aspen Szostek; Joaquín Maximiliano Espinosa
Journal:  Cell Cycle       Date:  2007-08-13       Impact factor: 4.534

3.  CDK8 is a stimulus-specific positive coregulator of p53 target genes.

Authors:  Aaron Joseph Donner; Stephanie Szostek; Jennifer Michelle Hoover; Joaquin Maximiliano Espinosa
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

4.  Mechanisms of regulatory diversity within the p53 transcriptional network.

Authors:  J M Espinosa
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

Review 5.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

6.  Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Authors:  Kensuke Kumamoto; Elisa A Spillare; Kaori Fujita; Izumi Horikawa; Taro Yamashita; Ettore Appella; Makoto Nagashima; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

7.  p53 regulates Hsp90beta during arsenite-induced cytotoxicity in glutathione-deficient cells.

Authors:  Geetha M Habib
Journal:  Arch Biochem Biophys       Date:  2008-10-26       Impact factor: 4.013

8.  Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.

Authors:  Sanjeev Shangary; Ke Ding; Su Qiu; Zaneta Nikolovska-Coleska; Joshua A Bauer; Meilan Liu; Guoping Wang; Yipin Lu; Donna McEachern; Denzil Bernard; Carol R Bradford; Thomas E Carey; Shaomeng Wang
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

9.  Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells.

Authors:  Matthew T Balmer; Ryan D Katz; Si Liao; James S Goodwine; Susannah Gal
Journal:  Cancer Biol Ther       Date:  2014-05-06       Impact factor: 4.742

10.  DNA damage response to the Mdm2 inhibitor nutlin-3.

Authors:  Rajeev Verma; Marc J Rigatti; Glenn S Belinsky; Cassandra A Godman; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.